This page explains what AOD 9604 is, what the research actually describes, and why the dosing question belongs in a clinical evaluation rather than a search result
AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone
The nurse remained in the treatment room for a considerable portion of the total time discussing products, expected results, time until effects felt, and related medical issues because she had time to do so
Isnt this odd?- And some would say ridiculous or even immoral
Patients with active malignancies, pregnancy, or significant hormonal imbalances should not use investigational peptides without specialist clearance
in extremely deficient areas, repeat dose every 2 - 3 months